\-\ Texto\\:\\ \ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ \\ no\\ specific\\ diagnostic\\ tests\\ are\\ available\\ for\\ psoriatic\\ arthritis\\.\ \(0\)\
\-\ \\ esr\\ \\-\\ elevated\\.\ \(0\)\
\-\ initial\\ treatment\\ is\\ nsaids\\ for\\ joint\\ disease\\ and\\ topicals\\ for\\ the\\ skin\\.\ \(0\)\
\-\ 2nd\\ line\\ therapy\\ includes\\ sulfasalazine\\,\\ cyclosporine\\.\ \(0\)\
\-\ 3rd\\ line\\ and\\ experimental\\ therapies\\ \\(biologic\\ response\\ modifiers\\)include\\ tnf\\-neutralizing\\ agents\\ like\\ infliximab\\.\ \(0\)\
\-\ inflammatory\\ erosive\\ arthritis\\ involving\\ the\\ hands\\ and\\ more\\ prominently\\ the\\ feet\\ with\\ evidence\\ of\\ bone\\ production\\ and\\ changes\\ of\\ central\\ destruction\\ especially\\ at\\ the\\ dip\\ joints\\.\ \(0\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ 1\\.\\ \\ psoriatic\\ arthritis\ \(0\)\
\-\ 2\\.\\ \\ reactive\\ arthritis\\ \\(reiter\\)\ \(0\)\
\-\ 3\\.\\ \\ ankylosing\\ spondylitis\ \(0\)\
\-\ 4\\.\\ \\ rheumatoid\\ arthritis\ \(0\)\
\-\ 40\\ year\\ old\\ male\\ with\\ inflammatory\\ joint\\ disease\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ arthritis\\:\\ 0\\.19733688919151268\ \(0\)\
\-\ psoriatic\\:\\ 0\\.1392420750766717\ \(0\)\
\-\ \\-\\:\\ 0\\.09901234911937101\ \(0\)\
\-\ topicals\\:\\ 0\\.07941908490059908\ \(0\)\
\-\ tnf\\-neutralizing\\:\\ 0\\.07941908490059908\ \(0\)\
\-\ modifiers\\:\\ 0\\.07317451570636534\ \(0\)\
\-\ biologic\\:\\ 0\\.0669299465121316\ \(0\)\
\-\ infliximab\\:\\ 0\\.0669299465121316\ \(0\)\
\-\ sulfasalazine\\:\\ 0\\.06491964424803962\ \(0\)\
\-\ line\\:\\ 0\\.06328312641274635\ \(0\)\
\-\ cyclosporine\\:\\ 0\\.0618883628370377\ \(0\)\
\-\ experimental\\:\\ 0\\.0618883628370377\ \(0\)\
\-\ prominently\\:\\ 0\\.05867507505380588\ \(0\)\
\-\ inflammatory\\:\\ 0\\.05339308007553196\ \(0\)\
\-\ reiter\\:\\ 0\\.05289260761081133\ \(0\)\
\-\ therapies\\:\\ 0\\.051571855591064704\ \(0\)\
\-\ dip\\:\\ 0\\.051171389261597734\ \(0\)\
\-\ joint\\:\\ 0\\.049791518108866326\ \(0\)\
\-\ production\\:\\ 0\\.04664803841657759\ \(0\)\
\-\ ankylosing\\:\\ 0\\.04664803841657759\ \(0\)\
\-\ spondylitis\\:\\ 0\\.04596348069605577\ \(0\)\
\-\ erosive\\:\\ 0\\.04574638563678495\ \(0\)\
\-\ agents\\:\\ 0\\.04512482823600161\ \(0\)\
\-\ nsaids\\:\\ 0\\.04153897121239219\ \(0\)\
\-\ tests\\:\\ 0\\.040285702721737066\ \(0\)\
\-\ hands\\:\\ 0\\.03982945287652306\ \(0\)\
\-\ feet\\:\\ 0\\.03939519970699263\ \(0\)\
\-\ esr\\:\\ 0\\.038980919407516745\ \(0\)\
\-\ response\\:\\ 0\\.03858485523255173\ \(0\)\
\-\ 2nd\\:\\ 0\\.038393166958251866\ \(0\)\
\-\ 3rd\\:\\ 0\\.038113071579242576\ \(0\)\
\-\ destruction\\:\\ 0\\.03802160877326044\ \(0\)\
\-\ reactive\\:\\ 0\\.03643994413964714\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.036363918295990706\ \(0\)\
\-\ like\\:\\ 0\\.03563699116761104\ \(0\)\
\-\ joints\\:\\ 0\\.0352274202299826\ \(0\)\
\-\ 40\\:\\ 0\\.0323888522422358\ \(0\)\
\-\ specific\\:\\ 0\\.031822654911968555\ \(0\)\
\-\ especially\\:\\ 0\\.03168649601277893\ \(0\)\
\-\ includes\\:\\ 0\\.03103495852107059\ \(0\)\
\-\ diagnostic\\:\\ 0\\.03050606121632484\ \(0\)\
\-\ 4\\.\\:\\ 0\\.03031063036397115\ \(0\)\
\-\ skin\\:\\ 0\\.029568729146297098\ \(0\)\
\-\ involving\\:\\ 0\\.027012678054083725\ \(0\)\
\-\ labs\\:\\ 0\\.026774540603019262\ \(0\)\
\-\ 3\\.\\:\\ 0\\.02634120911838493\ \(0\)\
\-\ elevated\\:\\ 0\\.026119967219451017\ \(0\)\
\-\ available\\:\\ 0\\.025880351791349523\ \(0\)\
\-\ initial\\:\\ 0\\.025509749038552323\ \(0\)\
\-\ central\\:\\ 0\\.025330012223963597\ \(0\)\
\-\ disease\\:\\ 0\\.02516644218406674\ \(0\)\
\-\ 2\\.\\:\\ 0\\.02448147875495728\ \(0\)\
\-\ 1\\.\\:\\ 0\\.024046749245924332\ \(0\)\
\-\ changes\\:\\ 0\\.022063495281396943\ \(0\)\
\-\ include\\:\\ 0\\.021595977369642222\ \(0\)\
\-\ therapy\\:\\ 0\\.0205823495156812\ \(0\)\
\-\ evidence\\:\\ 0\\.02018416741771962\ \(0\)\
\-\ for\\:\\ 0\\.0197056256389923\ \(0\)\
\-\ more\\:\\ 0\\.01925384062443393\ \(0\)\
\-\ bone\\:\\ 0\\.01913004217531414\ \(0\)\
\-\ treatment\\:\\ 0\\.015582134771179161\ \(0\)\
\-\ male\\:\\ 0\\.013920770611598857\ \(0\)\
\-\ \\(\\:\\ 0\\.013015526598988478\ \(0\)\
\-\ \\)\\:\\ 0\\.012856534993032524\ \(0\)\
\-\ are\\:\\ 0\\.010494359211978393\ \(0\)\
\-\ at\\:\\ 0\\.010430298674158857\ \(0\)\
\-\ \\:\\:\\ 0\\.0101826559999159\ \(0\)\
\-\ year\\:\\ 0\\.008613560984440672\ \(0\)\
\-\ old\\:\\ 0\\.007882293665425717\ \(0\)\
\-\ no\\:\\ 0\\.0077517491054396575\ \(0\)\
\-\ and\\:\\ 0\\.0064868110173772415\ \(0\)\
\-\ is\\:\\ 0\\.005065682688150682\ \(0\)\
\-\ the\\:\\ 0\\.004981956205536065\ \(0\)\
\-\ \\,\\:\\ 0\\.0024388294190746613\ \(0\)\
\-\ \\.\\:\\ 0\\.0022387094836164314\ \(0\)\
\-\ with\\:\\ 0\\.0021081833529709862\ \(0\)\
\-\ of\\:\\ 0\\.0020991675819457376\ \(0\)\
